Company intelligence / Profile preview

Biorelevant

Ownership: Private
Development stage: Commercial

Overview

Biorelevant supplies biorelevant dissolution media that simulate fasted and fed state gastrointestinal fluids. These products are widely used by pharmaceutical companies—including the ten largest globally—to predict oral drug solubility and dissolution behavior during preclinical formulation development. The company does not conduct clinical trials or have its own therapeutic pipeline but is an established partner to R&D teams worldwide.

Modalities: Small molecule drugsBiologics
Industry: Drug Discovery Services

Partnerships

Major global pharmaceutical companies

Beyond the preview

Go deeper on Biorelevant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorelevant.

Explore the full profile